Preventing Pruritus in Atopic Dermatitis: Are Biologics an Answer?
Preventing Pruritus in Atopic Dermatitis: Are Biologics an Answer
This activity is supported by educational grants from Sanofi and Regeneron Pharmaceuticals and Galderma.
At the completion of this activity, participants should be better able to:
Discuss the burden of itch on quality of life
Describe the pathophysiology of itch in atopic dermatitis
Analyze safety and efficacy data for current and emerging biologic therapies that target itch pathways in atopic dermatitis
Demonstrate strategies to individualize care to manage itch with biologic therapies in atopic dermatitis
Susan Taylor, MD
Incoming President-elect, American Academy of Dermatology
Bernett L. Johnson Endowed Professor in Dermatology
Perelman School of Medicine, University of Pennsylvania
Joshua Zeichner, MD
Director of Cosmetic and Clinical Research
Icahn School of Medicine at Mount Sinai
New York, NY
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Advisory Board: AbbVie, Avita Medical, Beiersdorf, Biorez (past), Eli Lilly, EPI Health, Evolus, Galderma, Hugel America, Incyte, Johnson & Johnson, L'Oreal USA, Medscape, Pfizer, Scientis US, UCB, Vichy Laboratoires Grant/Research Support: Allergan Aesthetics, Concert Pharmaceuticals/Sun Pharma, Croma Pharma GmbH, Eli Lilly, Pfizer Consultant: Arcutis, Armis Scientific, Beiersdorf, Bristol Myers Squibb, Cara Therapeutics, Dior, GloGetter, Piction Health, Sanofi Speakers’ Bureau or Honoraria: Beiersdorf, Medscape, MJH Lifesciences Royalty: McGraw Hill Publishing Ownership Interest (privately held): Armis Scientific, GloGetter, Piction Health Other Financial Benefit: Mercer Strategies LLC
Consultant: Abbvie, Allergan, Arcutis, Beiersdorf, Dermavant, Galderma, Incyte, Kenvue, L'Oreal, Pfizer, Procter & Gamble, Sun, Unilever, UCB
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.